RTX Corporation Morgan Stanley's 14th Annual Laguna Conference
Review the key takeaways and the transcript of this earnings call.
- RTX reported 13% organic sales growth, 21% year-over-year adjusted EPS growth, and about 4 billion in free cash flow in the first half of the year.
- RTX's backlog was 289 billion, up 22% year over year, and Raytheon's 12-month rolling book to bill at the end of Q2 was 1.77.
- GTF MRO was up 30% year over year in the first half of the year, Raytheon's critical munitions output doubled, and Collins reported 20% sales growth on OE in the first half of the year.
- Raytheon's backlog was 48% international, up 4 points from a year ago.
- GTF MRO output was up 40% year over year in Q2, while the AOG situation was down 25% since the end of last year.
- Collins reported 12% organic sales growth with a reduction in indirect headcount in the first half of the year.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Hi. Good morning, everyone. I'm Kristine Liwag, Morgan Stanley's Aerospace and Defense analyst. Very excited to host our next panel. We have RTX, Chris Calio, who is Chairman, President, and CEO. Welcome, Chris. Good morning, Kristine.
Great to be here. Great.
To get started, we'll start with, I'll read some disclosures, and Chris will read some disclosures as well, and we'll dive right in. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. I know you've got disclosures as well.
I'll keep it simple. I'll be making some forward-looking statements this morning. Of course, those come with certain risks and uncertainties, so please consult our SEC filings for those. Kristine, maybe I'll just make some brief opening remarks to sort of frame up what we're going to talk about today.
Wonderful. Go ahead. Yeah, great.
Good morning, everybody. Here at RTX, we have very strong conviction that we're exceptionally well-positioned in the aerospace and defense landscape with our three industry-leading businesses, Pratt & Whitney, Collins, and Raytheon. If you think about Pratt & Whitney, it's got the best small engine company in Pratt & Whitney Canada, over 70,000 engines in service, number 1 and number 2 in virtually all of its sub-segments. Our military engine business is sole source on some of the highest priority platforms in defense today. Think F-35, B-21, and of course, we've got the GTF, 8,000 engines in service, and a long tail of deliveries ahead of us. At Collins, you've got a portfolio that is number 1 or number 2 in 70% of its product segments. It's got 2x the content on new platforms than it did on legacy platforms.
It's got about $105 billion of out-of-warranty equipment flying around today. If you think of Pratt and Collins, not only are they riding the wave of the OE and aircraft demand that's out there today, everything they're delivering is going to have a very long and lucrative aftermarket tail to it. Then, of course, there's Raytheon, which has defense franchises across the company, which is critical to defending the U.S. and our allies. You're reading about it every day, protecting people and critical infrastructure. It's got 35 systems in operation today in 50 countries, and a significant backlog. I think if you look at the end of Q2, the 12-month rolling book-to-bill is 1.77.
Wow. Incredible demand for the product.
We've just recently signed up the UCA for our Tomahawk. We'll be adding that to our backlog here in the third quarter. When you think about that product portfolio, it is just very well-positioned to take advantage of the demand we're seeing in aerospace and defense. That's evidenced by the $289 billion backlog that we've got across RTX. That's up 22% year-over-year. Just incredible demand. It is real, and it is enduring. I'll tell you, our focus, of course, is on executing on this backlog, and we're seeing real momentum, in our execution, our operational focus. If you think through the first half of the year, 13% organic sales growth, 21% year-over-year, adjusted EPS growth, and we generated about $4 billion in free cash flow.
Really good operational progress here in the first half of the year. Of course, we're in a long cycle business, and while execution day in, day out of that backlog is critical to our customers and to our results, we've got to continue to look over the horizon to make sure that we've got the right technologies to fill our pipeline as we move forward, and that we're making sure that we're investing in the newest tools and systems to design and manufacture our products. This year we'll invest about $10.5 billion in company and customer-funded E&D and CapEx to make sure that we are staying very healthy in terms of the product pipeline, delivering on our backlog today, and making sure that we stay competitive well into the future. Last thing I would just say, Kristine, is no change to our full-year outlook.
We still remain on track. With that said, we're starting to see some IEEPA refunds start to flow through here in the third quarter and into the fourth quarter, and so we'll provide an update on that as we kind of move forward. With that, I'll put it back into your capable hands.
Chris, your opening statement just reminded us of the breadth of your portfolio. If you guys are shopping for a biz jet, the Gulfstream G600 is powered by Pratt & Whitney.
Thank you. I do not get a fee.
We are not paying any commissions today to you, Kristine, but yes, thank you.
You are absolutely right. I will take 1%.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
2 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
